NCT00819104 - A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components | Biotech Hunter

Enrollment

402

Participants

Timeline

Start Date

November 30, 2008

Study Completion Date

August 31, 2009

Conditions

Primary Hypertension

Interventions

DRUG

Metoprolol XL 50mg + Amlodipine 5mg

tablet,oral,OD,8 weeks

DRUG

Metoprolol XL 25 mg + Amlodipine 2.5mg

tablet,oral,OD,8 weeks

DRUG

Metoprolol XL 50mg

tablet,oral,OD,8 weeks

DRUG

Metoprolol XL 25 mg

tablet,oral,OD,8 weeks

DRUG

Amlodipine 5mg

tablet,oral,OD,8 weeks

Trial Locations (11)

Research Site, Hyderabad

Research Site, Ahmedabad

Research Site, Bangalore

Research Site, Calicut

Research Site, Mumbai

Research Site, Pune

Research Site, Delhi

Research Site, Jaipur

Research Site, Lucknow

Research Site, Kolkata

Research Site, Bangalore